Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases (original) (raw)
Bicyclic Boronate β‐Lactamase Inhibitors: The Present Hope against Deadly Bacterial Pathogens
Concepcion Gonzalez-Bello
Advanced Therapeutics, 2021
View PDFchevron_right
Boronic acid transition state inhibitors (BATSIs) active against KPC and other class A β-lactamases: structure activity relationships (SAR) as a guide to inhibitor design
Magdalena Taracila
Antimicrobial agents and chemotherapy, 2016
View PDFchevron_right
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
David Griffith
Journal of Medicinal Chemistry, 2020
View PDFchevron_right
Activity of the β-Lactamase inhibitor LN-1-255 against carbapenem-hydrolyzing class D β-lactamases from Acinetobacter baumannii
John Buynak
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Design, Synthesis, Crystal Structures, and Antimicrobial Activity of Sulfonamide Boronic Acids as β-Lactamase Inhibitors
Kerim Babaoglu, Joel Karpiak
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative
Cecilia Pozzi, Donatella Tondi
Journal of Medicinal Chemistry, 2014
View PDFchevron_right
Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases
Claudia Ibacache
Scientific reports, 2017
View PDFchevron_right
Evaluation of inhibitory action of novel non β-lactam inhibitor against Klebsiella pneumoniae carbapenemase (KPC-2)
asad khan
PloS one, 2014
View PDFchevron_right
Crystal Structures of KPC-2 β-Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226
DANIEL FERNANDEZ
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030
Nhu Quynh Nguyen
Antimicrobial agents and chemotherapy, 2016
View PDFchevron_right
C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation
Weirui Chai
mBio
View PDFchevron_right
Crystal Structures of KPC-2 -Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226
John Buynak
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
In Vivo Activity of QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor, in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae
David Griffith
Antimicrobial Agents and Chemotherapy, 2020
View PDFchevron_right
Structural analysis of the boronic acid β-lactamase inhibitor vaborbactam binding to Pseudomonas aeruginosa penicillin-binding protein 3
Shreya Agarwal
PLOS ONE, 2021
View PDFchevron_right
Design, Synthesis, and Crystal Structures of 6-Alkylidene-2′-Substituted Penicillanic Acid Sulfones as Potent Inhibitors of Acinetobacter baumannii OXA-24 Carbapenemase
Jared Sampson
Journal of the American Chemical Society, 2010
View PDFchevron_right
Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors
Leighanne Basta
ACS Infectious Diseases
View PDFchevron_right
Carbapenemase Inhibitors: Updates on Developments in 2021
waleed shaker
Journal of Clinical Medicine Research
View PDFchevron_right
Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases
Robert Bonomo
Biochemistry, 2007
View PDFchevron_right
Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis
Saugata Hazra
2014
View PDFchevron_right
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors
Magdalena Taracila
Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Evolving Carbapenemases: Can Medicinal Chemists Advance One Step Ahead of the Coming Storm
Jeffrey Toney
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
Narender Pottabathini
ACS Infectious Diseases, 2018
View PDFchevron_right
Current Challenges in Antimicrobial Chemotherapy: Focus on β-Lactamase Inhibition
Carine Bebrone
Drugs, 2010
View PDFchevron_right
Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase
Clyde Smith
Antimicrobial Agents and Chemotherapy, 2019
View PDFchevron_right
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii
Robert Bonomo
Antibiotics
View PDFchevron_right